Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 1:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1081–1104 of 1,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Eye Diseases
Interventions: Automated Telephone System, Personalized Telephone Call, Usual Care; Behavioral
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer, Screening Mammography, Community Health Worker
Interventions: Mammography with Community Health Worker (individual), Mammography with Community Health Worker (group), Standard of Care Mammography; Behavioral · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 40 Years to 64 Years · Female only
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Feeding Behavior
Interventions: Repeated Exposure; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 9 Months to 12 Months
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Cervical Carcinoma
Interventions: Health Promotion and Education, Survey Administration, Interview; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV Infections
Interventions: Treatment Text (TXTXT), Standard of Care; Behavioral
Lead sponsor: Amy K. Johnson, PhD, MSW; Other
Eligibility: 16 Years to 35 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 12
States / cities: Fort Lauderdale, Florida • Chicago, Illinois • Indianapolis, Indiana + 7 more

Conditions: Sleep Disorder, Healthy
Interventions: Sleep Fragmentation, Within-Subject test of blinded study medication (stimulant, benzodiazepine, opioid, cannabinoid, over-the-counter pain medication, or placebo), Sleep Continuity Disruption, Undisturbed Sleep; Behavioral · Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 48 Years
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Nasal Sinus; Inflammation, Opioid Abuse, Pain, Postoperative
Interventions: Ibuprofen 600Mg Tablet, Standard Regimen | Tylenol; Drug · Other
Lead sponsor: University of Nebraska; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Omaha, Nebraska • Cincinnati, Ohio

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Interventions: Best Practice, Internet-Based Intervention, Questionnaire Administration; Other · Behavioral
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Malignant Neoplasms of Lip Oral Cavity and Pharynx, Head and Neck Cancer
Interventions: Yoga, Yoga Questionnaire, Symptom Questionnaires; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cigarette Smoking, Drug Use
Interventions: Standard Treatment, BAD-AS, Transdermal Nicotine Patch; Behavioral · Drug
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 18 Years to 65 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: HIV Seropositivity
Interventions: Social Network Support Intervention; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 49 Years
Enrollment: 900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 7
States / cities: Birmingham, Alabama • Huntsville, Alabama • Chicago, Illinois + 1 more

Conditions: Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS), Juvenile Myelomonocytic Leukemia (JMML), Acute Lymphoblastic Leukemia (ALL), Lymphoma (Hodgkin's and Non-Hodgkin's)
Interventions: CliniMACS CD34+ Reagent System, Thiotepa, Cyclophosphamide, Alemtuzumab, Tacrolimus, Melphalan, Busulfan, Fludarabine, Methylprednisolone; Device · Drug
Lead sponsor: Diane George; Other
Eligibility: Up to 22 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Postoperative Nausea
Interventions: Ondansetron; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Tobacco Use Disorder
Interventions: Varenicline, Contingency Management, Counseling; Drug · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 40 Years
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 3
States / cities: Charleston, South Carolina • Florence, South Carolina • Pickens, South Carolina

Conditions: Breast Cancer
Interventions: Linear Aerobic Training, Nonlinear Aerobic Training, Progressive Stretching, Cardiopulmonary exercise test (CPET), Blood draws; Behavioral · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 45 Years to 80 Years · Female only
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Thromboembolic Pulmonary Hypertension
Interventions: Selexipag, Placebo; Drug
Lead sponsor: Actelion; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 32
States / cities: La Jolla, California • Los Angeles, California • Aurora, Colorado + 25 more

Conditions: Precancerous Condition
Interventions: Rituximab; Biological
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 90 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Cancer
Interventions: mFOCUS; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 80 Years
Enrollment: 11,980 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Boston, Massachusetts • Hanover, New Hampshire

Conditions: Allergic Diseases, Asthma
Interventions: Vaginal seeding, Placebo Seeding, Standard care, Post-seeding Care; Drug · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 2
States / cities: New York, New York

Conditions: Chemotherapy-induced Nausea and Vomiting
Interventions: Aprepitant 125 mg, Fosaprepitant 115 MG, Dexamethasone, Ondansetron 16 MG; Drug
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Choanal Atresia
Interventions: Drug-eluting Stent Mometasone; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Up to 10 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Diabetes Mellitus, Type 2
Interventions: Coached Care, Standard Diabetes Education; Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 540 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 3
States / cities: Newport Beach, California • Orange, California • Westminster, California

Conditions: Parenting, Mother-Child Relations, Child Development
Interventions: Precision Family Spirit, Standard Family Spirit; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 14 Years and older · Female only
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Sault Ste. Marie, Michigan

Conditions: Atrial Fibrillation
Interventions: Metformin; Drug
Lead sponsor: The Guthrie Clinic; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Sayre, Pennsylvania

Search by objective public record fields.

Improving Follow-Up Adherence in a Primary Eye Care Setting

Promotora Navigator - Culturally Appropriate Patient Navigator

Healthy Starts: Repeated Exposure Pilot

Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results

Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug

Pain Management Following Sinus Surgery

Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer

Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers

Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment

Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women

Cannabis and Tobacco Co-use Study

Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

mFOCUS (Multilevel FOllow-up of Cancer Screening)

Vaginal Microbiome Exposure and Immune Responses in C-section Infants

Low Dose Aprepitant for Patients Receiving Carboplatin

Use of Mometasone Eluting Stent in Choanal Atresia

Understanding and Improving Diabetes Care for Ethnic Minorities

Piloting a Precision Approach to Home Visiting

Metformin as an Upstream Therapy in Atrial Fibrillation